Keyphrases
Thrombotic
100%
Resilience
100%
Substance Use Disorder
100%
ADAMTS13
100%
Thrombotic Thrombocytopenic Purpura
75%
Adulthood
42%
Heat-inactivated
31%
High Resilience
28%
Connor-Davidson Resilience Scale
28%
Adverse childhood Experiences
28%
Childhood Experience
28%
Immune Thrombocytopenia
25%
Plasma Samples
25%
Healthy Donors
18%
Thrombotic Microangiopathy
18%
Positive Treatment
14%
Positive Experiences
14%
Resilience Score
14%
Childhood Play
14%
Self-agency
14%
Upbringing
14%
Substance Use Recovery
14%
Relapse Risk
14%
Childhood Environment
14%
Long-term Resilience
14%
AuGe
14%
Lasting Impact
14%
Treatment Model
14%
Pearson Correlation
14%
Demographic Information
14%
Treatment Outcome
14%
Experiential Research
14%
Self-report Survey
14%
Well-defined
14%
Mental Health Care
14%
Well-being
14%
Valuable Insight
14%
Potential Therapeutics
14%
Sectional Analysis
14%
Abstinence
14%
Nurture
14%
Calcium Chloride
12%
Platelet Factor 4
12%
Clinical Symptoms
12%
Activity Level
12%
Patient Samples
12%
Cattle
12%
HEPES
6%
Metal Chelates
6%
Treatment-seeking Sample
6%
Medicine and Dentistry
Substance Use Disorder
100%
Von Willebrand Factor Cleaving Proteinase
100%
Thrombosis
100%
Thrombotic Thrombocytopenic Purpura
75%
Idiopathic Thrombocytopenic Purpura
25%
Thrombocyte Factor 4
18%
Microangiopathy
18%
Post-Hoc Analysis
16%
Abstinence
16%
Cross Sectional Study
16%
Self Report
16%
Mental Health
16%
Calcium Chloride
12%
Polysorbate 20
6%
Blood Vessel Injury
6%
Thrombocyte Adhesion
6%
HEPES
6%
Patient Population
6%
Anemia
6%
Blood Donor
6%
Thrombocytopenia
6%
Von Willebrand Factor
6%
Hemostat
6%
Metalloproteinase
6%
Renal Failure
6%
Malignant Hypertension
6%
Atypical Hemolytic Uremic Syndrome
6%
Buffer
6%
Heparin-Induced Thrombocytopenia
6%
Coagulopathy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombosis
100%
Von Willebrand Factor Cleaving Proteinase
100%
Thrombotic Thrombocytopenic Purpura
75%
Idiopathic Thrombocytopenic Purpura
25%
Thrombocyte Factor 4
18%
Microangiopathy
18%
Bovine
12%
Calcium Chloride
12%
Malignant Hypertension
6%
HEPES
6%
Hemolytic Uremic Syndrome
6%
Hemostatic Agent
6%
Blood Vessel Injury
6%
Polysorbate 20
6%
Blood Clotting Disorder
6%
Von Willebrand Factor
6%
Syndrome
6%
Heparin Induced Thrombocytopenia
6%
Buffer
6%
Metalloproteinase
6%
Kidney Failure
6%
Anemia
6%
Thrombocytopenia
6%
